Advertisement
Singapore markets closed
  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • Dow

    38,239.98
    +253.58 (+0.67%)
     
  • Nasdaq

    15,451.31
    +169.30 (+1.11%)
     
  • Bitcoin USD

    66,166.55
    -26.44 (-0.04%)
     
  • CMC Crypto 200

    1,420.19
    +5.43 (+0.38%)
     
  • FTSE 100

    8,034.75
    +10.88 (+0.14%)
     
  • Gold

    2,324.00
    -22.40 (-0.95%)
     
  • Crude Oil

    81.12
    -0.78 (-0.95%)
     
  • 10-Yr Bond

    4.6460
    +0.0230 (+0.50%)
     
  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     
  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     
  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

How Roche’s HER2 Franchise Is Positioned in August

How Roche’s HER2 Franchise Is Positioned in August

Roche’s (RHHBY) Herceptin reported revenues of 3.6 billion Swiss francs in the first half compared to 3.5 billion Swiss francs in the first half of 2017, reflecting ~2.0% YoY year-over-year growth at CER (constant exchange rates).